CHARLES SCHWAB INVESTMENT MANAGEMENT INC - VOR BIOPHARMA INC ownership

VOR BIOPHARMA INC's ticker is VOR and the CUSIP is 929033108. A total of 60 filers reported holding VOR BIOPHARMA INC in Q1 2023. The put-call ratio across all filers is 0.07 and the average weighting 0.4%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of VOR BIOPHARMA INC
ValueSharesWeighting
Q3 2023$220,306
-31.4%
103,9180.0%0.00%
Q2 2023$321,107
+235.5%
103,918
+484.1%
0.00%
Q1 2023$95,721
+32.4%
17,792
+63.6%
0.00%
Q4 2022$72,319
+64.4%
10,8750.0%0.00%
Q3 2022$44,000
-78.7%
10,875
-73.8%
0.00%
Q2 2022$207,000
-63.4%
41,476
-55.7%
0.00%
Q1 2022$566,000
-47.3%
93,586
+1.4%
0.00%
Q4 2021$1,073,000
-23.5%
92,335
+3.2%
0.00%
Q3 2021$1,403,000
+8.9%
89,456
+29.6%
0.00%
Q2 2021$1,288,000
-59.2%
69,030
-5.7%
0.00%
-100.0%
Q1 2021$3,157,00073,2410.00%
Other shareholders
VOR BIOPHARMA INC shareholders Q1 2023
NameSharesValueWeighting ↓
5AM Venture Management, LLC 6,361,723$34,226,0708.75%
OUP Management Co., LLC 374,714$2,015,9614.02%
Paradigm Biocapital Advisors LP 6,477,999$34,851,6353.30%
RA Capital Management 22,748,880$122,388,9742.77%
JOHNSON & JOHNSON 1,074,658$5,781,6601.88%
Artal Group S.A. 2,792,805$15,0250.89%
Trustees of Columbia University in the City of New York 91,910$494,4760.88%
Sarissa Capital Management LP 618,000$3,324,8400.42%
Laurion Capital Management LP 3,182,889$17,123,9430.12%
Woodline Partners LP 1,111,123$5,977,8420.08%
View complete list of VOR BIOPHARMA INC shareholders